Nanotechnology is rewriting the rules of cancer immunotherapy—turning microscopic carriers into programmable weapons that hunt, penetrate, and destroy tumors while training the immune system for lifelong defense.

Based on original, futuristic research conducted for presentation at the upcoming Cancer 2026 conference in Singapore, this book delivers a complete forward-looking blueprint of how nanotechnology will reshape cancer immunotherapy through 2026 and 2027. It is not based on any academic syllabus. It is born from independent, cutting-edge investigation into what comes next.

Inside these pages, you will discover how lipid nanoparticles unlock genetic cargo inside cells. You will learn why tumors build walls that block medicine. You will see how artificial intelligence invents molecules no human has imagined. You will follow microrobots swimming through scar tissue. You will witness cold tumors igniting into immune battlegrounds. Every chapter builds upon the last. Yet what happens when one nanoparticle carries three weapons at once? What occurs when a digital twin adjusts your dose every Tuesday? The answers will change how you see medicine forever.

What sets this book apart from every other nanomedicine reference is simple: it speaks the language of tomorrow. Most published texts still describe outdated EPR assumptions and first-generation coatings. This book delivers the 2026–2027 reality: active transcytosis, in vivo CAR-T generation, post-PEG stealth polymers, AI-generated lipids, Piezo1 mechanobiology, and closed-loop adaptive dosing. No other single volume connects multi-omics profiling, biohybrid microrobots, bispecific antibodies, and theranostic imaging into one unified clinical blueprint. This is the bridge between scattered journals and actionable understanding—written for researchers, clinicians, and biotech leaders preparing for the next frontier.

Disclaimer: The author declares no affiliation with any medical board, pharmaceutical company, or regulatory body. This work is independently produced under nominative fair use for academic commentary. No proprietary formulations or registered trademarks are reproduced. This is the entirely original intellectual work of the author.

About the Author: Azhar ul Haque Sario is a government-registered scientist under Pakistan's Ministry of Science and Technology and a world-record holder recognized by the Asia Book of Records for publishing 2,810 books in one year. Ranked in the top 2.5% of researchers globally, he bridges immunology, analytics, and nanomedicine. His work is distributed worldwide under the Azhar Sario Hungary imprint.

Nanotechnology in Immunotherapy: Targeted Delivery Systems in the Cancer Battle is an original, independent publication not affiliated with or endorsed by any institution. All scientific references are used solely for educational purposes under nominative fair use. No trademarks are claimed. © 2026 Azhar ul Haque Sario. All rights reserved.